期刊
ACS MEDICINAL CHEMISTRY LETTERS
卷 3, 期 9, 页码 731-735出版社
AMER CHEMICAL SOC
DOI: 10.1021/ml3001352
关键词
plasma stability; computer-aided drug design; SAR; acrylamides; Celiac disease; ADME
A new series of potent TG2 inhibitors are reported that employ a 4-aminopiperidine core bearing an acrylamide warhead. We establish the structure activity relationship of this new series and report on the transglutaminase selectivity and in vitro ADME properties of selected compounds. We demonstrate that the compounds do not conjugate glutathione in an in vitro setting and have superior plasma stability over our previous series.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据